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atrophy in the duodenal biopsy. All patients had intraepi-
thelial lymphocytosis without villous atrophy. Clinical 
response was defined as achieving at least one of the fol-
lowing scenarios: remission of FM pain criteria, return to 
work, return to normal life, or the discontinuation of opi-
oids. The mean follow-up period was 16 months (range 
5–31). This observation supports the hypothesis that non-
celiac gluten sensitivity may be an underlying cause of FM 
syndrome.
Keywords Fibromyalgia · Celiac disease · Gluten 
sensitivity · Intraepithelial lymphocytosis
Introduction
Fibromyalgia (FM) is a commonly recognized syndrome 
characterized by pain, sleep disturbance, and fatigue 
combined with a general increase in medical symptoms, 
including problems of memory or thinking, and often psy-
chological distress [1]. The pharmacological treatment 
of FM results in only partial relief [2]. This condition is 
frequently associated with depression and irritable bowel 
syndrome.
Celiac disease (CD) is a frequent disease, affecting 
about 1 % of the population that can be diagnosed at all 
ages under different clinical settings. The classic presenta-
tion of CD is chronic diarrhea, positive anti-tissue transglu-
taminase antibodies (anti-tTG), and villous atrophy with 
intraepithelial lymphocytosis observed by duodenal biopsy. 
CD often does not conform to the classical clinical descrip-
tion, and up to 50 % of patients with adult CD lack promi-
nent gastrointestinal symptoms [3, 4]. Clinical manifesta-
tions of CD include muscle and osteoarticular pain, fatigue, 
and neurological and psychological symptoms [5, 6].
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Non-celiac gluten sensitivity is increasingly recognized 
as a frequent clinical condition with symptoms similar to 
CD in the absence of the diagnostic features of CD [7, 
8]. Intraepithelial lymphocytosis without villous atrophy 
and without specific celiac antibodies has been shown to 
be part of the spectrum of non-celiac gluten sensitivity. 
These mild gluten-related lesion have been given different 
names, such as gluten-sensitive enteropathy or mild celiac 
enteropathy [9–12]. The aim of this report is to describe 
selected patients with FM, non-celiac gluten sensitiv-
ity, duodenal intraepithelial lymphocytosis, and clinical 
response to gluten-free diet, in order to raise the hypoth-
esis that non-celiac gluten sensitivity could be a treatable 
cause of FM.
Methods
As part of a wider research project approved by the local 
ethics committee, patients diagnosed with FM and referred 
to a widespread chronic pain rheumatology unit were given 
the option to undergo fibrogastroscopy with duodenal 
biopsies, despite negative anti-tTG assay results, and gave 
informed consent for fibrogastroscopy knowing the nega-
tive results of the CD serology. After the pathology report 
ruled out CD, consented to participating in an open gluten-
free diet trial. Currently, we are following 246 patients of 
these patients. Clinical response has been observed in 90 of 
them. This is a report of the first patients for whom duode-
nal intraepithelial lymphocytosis and a clinical response to 
a gluten-free diet were observed. These patients also gave 
additional consent for their cases to be published, including 
their genetic data.
Duodenal biopsies were obtained from the second 
duodenal portion before beginning the GFD. These sam-
ples were retrospectively evaluated by three pathologists 
from two academic centers with anti-CD3 T-cell recep-
tor immunohistochemical stains. The identification of 
intraepithelial lymphocytosis was agreed upon by the 
three pathologists and considered to be present when 
the intraepithelial lymphocyte count was more than 25 
per 100 enterocytes [13–15]. HLA-DRB1, HLA-DQA1, 
and HLA-DQB1 alleles were determined from blood 
samples.
A trial of a strict gluten-free diet was conducted with the 
help and training of the CD Patients Association of Madrid. 
In addition, iron, vitamin D, and multivitamins supplements 
with oligoelements were prescribed. A lactose-free diet was 
also recommended when lactose intolerance was suspected 
on clinical grounds or demonstrated by a breath hydrogen 
test after lactose administration. Clinical response was 
defined as the achievement of at least one of the following 
scenarios: remission of FM pain criteria, return to work, 
return to normal life as judged by the patient, or opioid 
discontinuation.
Results
Twenty patients with FM are described for whom duode-
nal intraepithelial lymphocytosis and a clinical response to 
a gluten-free diet were observed. Table 1 shows the clini-
cal and HLA descriptions of each patient. All subjects were 
female. The mean subject age was 46 years (range 25–73). 
The mean duration of FM evolution was 11.9 years (range 
3–20). Eight patients had been diagnosed with chronic 
fatigue syndrome. Seventeen patients had a gastrointes-
tinal disorder (irritable bowel syndrome, gastroesopha-
geal reflux, constipation, dyspepsia, hiatal hernia, lactose 
intolerance, or nonspecific colitis). Other diagnoses were 
depression (eight patients), migraine (eight patients), and 
hypothyroidism without improvement in FM with thyroid 
hormone substitution (three patients). Five patients had fea-
tures of undifferentiated spondyloarthritis, and one patient 
had psoriatic arthritis.
Eleven patients carried either the DQ2 (DQA1*05—
DQB1*02) or DQ8 (DQA1*0301–DQB1*0302) heterodi-
mers. Seven patients had only one allele of the DQ2 heter-
odimer, either DQB1*02 or DQA1*05. Two patients did not 
carry either DQ2 alleles or DQ8.
The mean follow-up period for the gluten-free diet was 
16.4 months (range 5–31). Eight patients were also on 
a lactose-free diet. For five of these eight patients, a lac-
tose-free diet had been attempted before the gluten-free 
diet, resulting in partial relief of the gastrointestinal symp-
toms but no improvement in the FM symptoms. For three 
patients (#4, 10, and 20), a lactose-free diet was started 
concurrently with the gluten-free diet.
The level of widespread chronic pain improved dramati-
cally for all patients; for 15 patients, chronic widespread 
pain was no longer present, indicating remission of FM. 
Fifteen patients returned to work or normal life. In three 
patients who had been previously treated in pain units with 
opioids, these drugs were discontinued. Fatigue, gastroin-
testinal symptoms, migraine, and depression also improved 
together with pain. Patients #2 and #3, both with oral aph-
thae, went into complete remission for psoriatic arthritis 
and undifferentiated spondyloarthritis.
For some patients, the clinical improvement after start-
ing the gluten-free diet was striking and observed after 
only a few months; for other patients, improvement was 
very slow and was gradually observed over many months 
of follow-up. For eight patients (# 2, 3, 8, 9, 12, 14, 17, 19, 
and 20), the intake of gluten was followed by clinical wors-
ening, which subsided after returning to a strict gluten-free 
diet.
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Discussion
Here, we report the cases of patients with severe long-
standing FM in whom CD was ruled out, but had duode-
nal intraepithelial lymphocytosis and exhibited clinical 
responses to a gluten-free diet. The observation for FM 
patients of a histopathologic lesion associated with a treat-
able disease opens new perspectives.
The concept of non-celiac gluten sensitivity arises from 
clinical observations of patients whose symptoms clearly 
improve or resolve with a gluten-free diet even though CD 
has been ruled out. Non-celiac gluten sensitivity is cur-
rently included in the wider concept of gluten-related disor-
ders, along with CD and wheat allergy [16].
In non-celiac gluten sensitivity, specific autoantibod-
ies are not present, and duodenal biopsy only reveals 
intraepithelial lymphocytosis or no pathologic changes. 
Only approximately half of patients with GS carry the 
HLA DQ2 or DQ8 heterodimers, in contrast to CD in 
which almost all patients carry the HLA DQ2 or DQ8. 
The symptoms of non-celiac gluten sensitivity include 
behavioral changes, bone or joint pain, muscle cramps, 
leg numbness, weight loss, chronic fatigue, and a foggy 
mind. Oral aphthae and psoriasis can also be due to non-
celiac gluten sensitivity [7]. Intraepithelial lymphocytosis 
has been the hallmark of gluten intestinal lesions since the 
first descriptions of the intestinal pathology of CD [17]. 
In the current classification criteria, a Marsh 1-type lesion 
is defined as the presence of more than 25 intraepithelial 
lymphocytes per one hundred enterocytes in a duodenal 
biopsy. Intraepithelial lymphocytosis can be overlooked 
or not considered relevant in a pathology report focused 
on villous atrophy or can be missed if anti-CD3 staining is 
not performed [13, 14]. Although intraepithelial lympho-
cytosis is associated with several other conditions, such 
as Helicobacter pylori disease, NSAID intake, Crohn’s 
disease, or parasitic infestation, gluten enteropathy must 
always be considered [18–20]. For our patients, intraepi-
thelial lymphocytosis was found by experienced patholo-
gists after a specific search. Two examples of intraepithe-
lial lymphocytosis are shown in Fig. 1, which presents 
images of CD3-stained preparations. The high frequency 
of HLA alleles related to susceptibility to CD in our 
patients is similar to that described in non-celiac gluten 
sensitivity.
The spectrum of symptoms of our patients is wide 
and complex, as is typical for FM and described in non-
celiac gluten sensitivity. The reduction in the level of 
pain was accompanied by improvements in asthenia and 
gastrointestinal and neurological symptoms, suggesting 
a common underlying cause related to gluten. The clini-
cal response definition for this report was decided upon 
after the initial observations of impressive improvement 
in some patients after starting the gluten-free diet. We 
chose demanding outcome measures, such as the remis-
sion of FM or return to normal life, rather than changes 
reflected by questionnaires. To our knowledge, this 
degree of improvement has not been reported previously 
for FM. It is unlikely that our results were caused by a 
placebo effect. The majority of patients had severe dis-
tress and disability and were unable to cope normally 
with daily activities or on sick leave, despite having been 
treated with many different regimens for years. In FM 
clinical trials, the placebo effect has been very modest 
and transient, in contrast to the great long-term improve-
ment of our patients. Lactose-free diet and the addition 
of vitamins could be confounders, but the majority of the 
patients with lactose-free diet had tried it before without 
improvement of FM, and in our experience FM does not 
have relevant clinical improvement just adding vitamins 
and minerals. Furthermore, the reintroduction of glu-
ten, for 7 patients, was followed by FM relapse; when 
re-introduced, the strict gluten-free diet led to clinical 
improvement.
Fig. 1  a CD3 staining of intraepithelial lymphocytes in the duodenal villi of patient #8. b CD3 staining of intraepithelial lymphocytes in the tips 
of the duodenal villi of patient #1
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This report describes the first patients for which we have 
observed FM with intraepithelial lymphocytosis and the 
response to a gluten-free diet. Currently, we are following 
246 patients with FM on a strict gluten-free diet, and the 
degree of clinical improvement described in this report has 
been observed in 90 of them. We still do not have long-term 
follow-up and CD3 staining data for all of our patients. 
However, it is worth communicating our first observations, 
which open a wide field for research. Indeed, non-celiac 
gluten sensitivity as a cause of FM, and the role of duo-
denal intraepithelial lymphocytosis, needs to be tested in a 
controlled trial.
Conclusion
This report shows that remarkable clinical improvement 
can be achieved with a gluten-free diet in patients with FM, 
even if CD has been ruled out, suggesting that non-celiac 
gluten sensitivity may be an underlying treatable cause of 
FM syndrome. The presence of intraepithelial lymphocyto-
sis in the duodenal biopsies of these selected patients fur-
ther supports this hypothesis.
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